Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study

Figure 5

Serious case of advanced BCC infiltrating and destruction of both eyelids in left eye, tear region, external wall of nostril and etmoids cells, constant exit of fetid liquid. The therapeutic schedule for this patient consisted of intralesional administration of IFN combination with concomitant Cisplatin followed by intramuscular IFN combination. The patient achieved a CR for more than 3 years.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us